Role of <i>Tafazzin</i> in Mitochondrial Function, Development and Disease

Role of <i>Tafazzin</i> in Mitochondrial Function, Development and Disease

<i>Tafazzin</i>, an enzyme associated with the rare inherited x-linked disorder Barth Syndrome, is a nuclear encoded mitochondrial transacylase that is highly conserved across multiple species and plays an important role in mitochondrial function. Numerous studies have elucidated the mec...

Full description

Bibliographic Details
Main Authors:	Michael T. Chin, Simon J. Conway
Format:	Article
Language:	English
Published:	MDPI AG 2020-05-01
Series:	Journal of Developmental Biology
Subjects:	<i>Tafazzin</i> mitochondria Barth syndrome rare X-linked genetic disease cardiolipin heart failure
Online Access:	https://www.mdpi.com/2221-3759/8/2/10

Similar Items

Phenotypic Characterization of Male <i>Tafazzin</i>-Knockout Mice at 3, 6, and 12 Months of Age
by: Michelle V. Tomczewski, et al.
Published: (2023-02-01)

Phenotypic Characterization of Female Carrier Mice Heterozygous for Tafazzin Deletion
by: Michelle V. Tomczewski, et al.
Published: (2023-09-01)

Metabolic switch from fatty acid oxidation to glycolysis in knock‐in mouse model of Barth syndrome
by: Arpita Chowdhury, et al.
Published: (2023-08-01)

Case Report: A Chinese child with Barth syndrome caused by a novel TAFAZZIN mutation
by: Mingxuan Che, et al.
Published: (2024-09-01)

Diminished exercise capacity and mitochondrial bc1 complex deficiency in tafazzin-knockdown mice.
by: Corey ePowers, et al.
Published: (2013-04-01)

Re-Expression of Tafazzin Isoforms in TAZ-Deficient C6 Glioma Cells Restores Cardiolipin Composition but Not Proliferation Rate and Alterations in Gene Expression
by: Gayatri Jagirdar, et al.
Published: (2022-07-01)

Corrigendum: Re-expression of tafazzin isoforms in TAZ-deficient C6 glioma cells restores cardiolipin composition but not proliferation rate and alterations in gene expression
by: Gayatri Jagirdar, et al.
Published: (2022-08-01)

Dysfunctional cardiac mitochondrial bioenergetic, lipidomic, and signaling in a murine model of Barth syndrome[S]
by: Michael A. Kiebish, et al.
Published: (2013-05-01)

Tafazzin gene mutations are uncommon causes of dilated cardiomyopathy in adults
by: Matthew Taylor, et al.
Published: (2011-07-01)

Studying Lipid-Related Pathophysiology Using the Yeast Model
by: Tyler Ralph-Epps, et al.
Published: (2021-10-01)

Reduction in mRNA Expression of the Neutrophil Chemoattract Factor CXCL1 in <i>Pseudomonas aeruginosa</i> Treated Barth Syndrome B Lymphoblasts
by: Hana M. Zegallai, et al.
Published: (2023-05-01)

Tafazzin Mutation Affecting Cardiolipin Leads to Increased Mitochondrial Superoxide Anions and Mitophagy Inhibition in Barth Syndrome
by: Patrice X. Petit, et al.
Published: (2020-10-01)

Case report: Variability in clinical features as a potential pitfall for the diagnosis of Barth syndrome
by: Nicola Tovaglieri, et al.
Published: (2023-08-01)

Role of Cardiolipin in Mitochondrial Signaling Pathways
by: Jan Dudek
Published: (2017-09-01)

Monolysocardiolipins accumulate in Barth syndrome but do not lead to enhanced apoptosis
by: Fredoen Valianpour, et al.
Published: (2005-06-01)

Tafazzin deficiency causes substantial remodeling in the lipidome of a mouse model of Barth Syndrome cardiomyopathy
by: Malte Hachmann, et al.
Published: (2024-04-01)

Barth syndrome: mechanisms and management
by: Finsterer J
Published: (2019-06-01)

Phosphatidylglycerol Supplementation Alters Mitochondrial Morphology and Cardiolipin Composition
by: I Chu, et al.
Published: (2022-03-01)

Overexpression of mitochondrial oxodicarboxylate carrier (ODC1) preserves oxidative phosphorylation in a yeast model of Barth syndrome
by: Maxence de Taffin de Tilques, et al.
Published: (2017-04-01)

A novel intronic splice site tafazzin gene mutation detected prenatally in a family with Barth syndrome
by: Bakšienė M, et al.
Published: (2016-12-01)

Cardiolipin remodeling maintains the inner mitochondrial membrane in cells with saturated lipidomes
by: Kailash Venkatraman, et al.
Published: (2024-08-01)

Expanded-access use of elamipretide in a critically ill patient with Barth syndrome
by: Amy C. Goldstein, et al.
Published: (2024-01-01)

Current Knowledge on the Role of Cardiolipin Remodeling in the Context of Lipid Oxidation and Barth Syndrome
by: Zhuqing Liang, et al.
Published: (2022-05-01)

Decreasing cytosolic translation is beneficial to yeast and human Tafazzin-deficient cells
by: Maxence de Taffin de Tilques, et al.
Published: (2018-02-01)

Stimulating the sir2–spargel axis rescues exercise capacity and mitochondrial respiration in a Drosophila model of Barth syndrome
by: Deena Damschroder, et al.
Published: (2022-10-01)

Cardiac‐specific succinate dehydrogenase deficiency in Barth syndrome
by: Jan Dudek, et al.
Published: (2015-12-01)

Aim24 and MICOS modulate respiratory function, tafazzin-related cardiolipin modification and mitochondrial architecture
by: Max Emanuel Harner, et al.
Published: (2014-04-01)

Prenatal case report of Barth syndrome caused by novel TAFAZZIN mutation: Clinical characteristics of fetal dilated cardiomyopathy with ascites
by: Xuliang Zhao, et al.
Published: (2022-11-01)

Role of Hippo Pathway Effector Tafazzin Protein in Maintaining Stemness of Umbilical Cord-Derived Mesenchymal Stem Cells (UC-MSC)
by: Madhumala Gopinath, et al.
Published: (2018-04-01)

Tafazzin modulates cellular phospholipid composition to regulate AML stemness
by: Ayesh K. Seneviratne, et al.
Published: (2019-09-01)

Metabolic Alterations Caused by Defective Cardiolipin Remodeling in Inherited Cardiomyopathies
by: Christina Wasmus, et al.
Published: (2020-11-01)

Late diagnosis of Barth syndrome in a 39‐year‐old patient with non‐compaction cardiomyopathy and neutropenia
by: Andreas Seitz, et al.
Published: (2020-04-01)

De novo biosynthesis of the late endosome lipid, bis(monoacylglycero)phosphates⃞
by: Françoise Hullin-Matsuda, et al.
Published: (2007-09-01)

The Loss of Tafazzin Transacetylase Activity Is Sufficient to Drive Testicular Infertility
by: Paige L. Snider, et al.
Published: (2024-11-01)

The Role of Cardiolipin as a Scaffold Mitochondrial Phospholipid in Autophagosome Formation: In Vitro Evidence
by: Valeria Manganelli, et al.
Published: (2021-02-01)

Linoleic acid supplemention of Barth syndrome fibroblasts restores cardiolipin levels: implications for treatment
by: F. Valianpour, et al.
Published: (2003-03-01)

Disorders of phospholipid metabolism: an emerging class of mitochondrial disease due to defects in nuclear genes
by: Ya-Wen eLu, et al.
Published: (2015-02-01)

Use of Elamipretide in patients assigned treatment in the compassionate use program: Case series in pediatric patients with rare orphan diseases
by: Mary Kay Koenig, et al.
Published: (2023-01-01)

Mitochondrial dysfunction and reduced prostaglandin synthesis in skeletal muscle of Group VIB Ca2+-independent phospholipase A2γ-deficient mice[S]
by: Emiko Yoda, et al.
Published: (2010-10-01)

Linoleate-Enrichment of Mitochondrial Cardiolipin Molecular Species Is Developmentally Regulated and a Determinant of Metabolic Phenotype
by: Genevieve C. Sparagna, et al.
Published: (2022-12-01)